The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis
Clinical and Experimental Dermatology · 2026
DOI: 10.1093/ced/llag088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Pei-Yu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome, Adalimumab, Immunoglobulins, Intravenous, Adrenal Cortex Hormones.
Abstract (Originalsprache)
Background
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous adverse drug reactions still with controversy in treatment. Complete blood cell count (CBC)-derived inflammatory biomarkers reflect systemic inflammation, and their value in SJS/TEN has not been fully studied.
Objective
To compare the therapeutic efficacy of corticosteroid combined with adalimumab (CA), corticosteroid combined with IVIG (CI) and corticosteroid monotherapy (CM), and explore prognosticators on severity and prognosis of SJS/TEN.
Methods
All SJS/TEN inpatients treated with CA, CI, or CM in two hospitals between 2015 and 2024 were studied. We calculated biomarkers including neutrophil/lymphocyte ratio (NLR), derived neutrophil/(leukocyte minus neutrophil) ratio (dNLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), and neutrophil/(lymphocyte × platelet) ratio (NLPR), and analyzed their correlations with severity and prognosis.
Results
Among 136 patients, 29 patients were treated with CA, 18 patients were treated with CI, and 89 patients were treated with CM. The mortality rate in three groups was much lower than expected based on SCORTEN. The time to original lesions improvement and time to no new lesions developing in CA and CI were significantly shorter than those in CM. NLR, dNLR, PLR, and NLPR were independent risk factors for the elevation of SCORTEN score, and MLR was an independent prognostic factor for healing time.
Conclusions
The therapeutic efficacy of CA and CI is better than CM, and the incidence of complications is not increased. NLR, dNLR, PLR, and NLPR may serve as potential prognosticators of severity in SJS/TEN. Higher MLR appears to be a potential poor prognostic factor for healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Department of Dermatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zitieren
APA
Wang, P. Y., Yu, T. H., Yin, G. W., & Li, L. F. (2026). The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag088
Vancouver
Wang PY, Yu TH, Yin GW, Li LF. The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag088
BibTeX
@article{Wang2026,
author = {Wang, Pei-Yu and Yu, Tian-Hang and Yin, Guang-Wen and Li, Lin-Feng},
title = {The effect of different therapies and complete blood cell count-derived inflammatory biomarkers on the prognosis of Stevens-Johnson syndrome and toxic epidermal necrolysis},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag088}
}
EUVIMED